Transarterial chemoembolization (TACE) in patients with unresectable diffuse vs. focal hepatocellular carcinoma (HCC).

被引:1
|
作者
Pan, SH [1 ]
Ramirez, C [1 ]
Hoffman, A [1 ]
Sher, L [1 ]
Rojter, S [1 ]
Lopez, RR [1 ]
机构
[1] St Vincents Med Ctr, Los Angeles, CA USA
关键词
D O I
10.1016/S0016-5085(00)86110-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1136
引用
收藏
页码:A991 / A991
页数:1
相关论文
共 50 条
  • [41] Combined Transarterial Chemoembolization (TACE) and Percutaneous Local Ablation Therapy for Advanced Hepatocellular Carcinoma (HCC)
    Kirikoshi, Hiroyuki
    Saito, Satoru
    Yoneda, Masato
    Fujita, Koji
    Mawatari, Hironori
    Nozaki, Yuichi
    Suzuki, Kaori
    Endo, Hiroki
    Takahashi, Hirokazu
    Abe, Yasunobu
    Inamori, Masahiko
    Kobayashi, Noritoshi
    Kubota, Kensuke
    Nakajima, Atsushi
    GASTROENTEROLOGY, 2010, 138 (05) : S809 - S810
  • [42] Efficacy of high-dose conformal radiotherapy (CRT) combined to transarterial chemoembolization (TACE) for large size unresectable hepatocellular carcinoma (HCC)
    Mornex, F.
    Cuinet, M.
    Marion, D.
    Wautot, V
    Maillard, E.
    Trépo, C.
    Merie, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 40 - 40
  • [43] Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)
    Andrea Veltri
    Paolo Moretto
    Andrea Doriguzzi
    Eva Pagano
    Giovanna Carrara
    Giovanni Gandini
    European Radiology, 2006, 16 : 661 - 669
  • [44] Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC)
    Veltri, A
    Moretto, P
    Doriguzzi, A
    Pagano, E
    Carrara, G
    Gandini, G
    EUROPEAN RADIOLOGY, 2006, 16 (03) : 661 - 669
  • [45] Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
    Tsung-Hsing Hung
    Chen-Chi Tsai
    Chung-Chi Lin
    Hsing-Feng Lee
    Chi-Jen Chu
    Han-Chieh Lin
    Hepatology International, 2013, 7 : 676 - 682
  • [46] Is transarterial chemoembolization beneficial for patients with diffuse infiltrative hepatocellular carcinoma?
    Hung, Tsung-Hsing
    Tsai, Chen-Chi
    Lin, Chung-Chi
    Lee, Hsing-Feng
    Chu, Chi-Jen
    Lin, Han-Chieh
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 676 - 682
  • [47] Transarterial Chemoembolization of Child-A hepatocellular carcinoma: Drug-eluting bead TACE (DEB TACE) vs. TACE with Cisplatin/Lipiodol (cTACE)
    Wiggermann, Philipp
    Sieron, Dominik
    Brosche, Christiane
    Brauer, Thomas
    Scheer, Fabian
    Platzek, Ivan
    Wawrzynek, Wojciech
    Stroszczynski, Christian
    MEDICAL SCIENCE MONITOR, 2011, 17 (04): : CR189 - CR195
  • [48] Sorafenib plus transarterial chemoembolization for unresectable hepatocellular carcinoma
    Tsilimigras, Diamantis I.
    Pawlik, Timothy M.
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (23)
  • [49] Transarterial Chemoembolization and Unresectable Hepatocellular Carcinoma: A Narrative Review
    Manjunatha, Nisha
    Ganduri, Vinutna
    Rajasekaran, Kruthiga
    Duraiyarasan, Shrimahitha
    Adefuye, Mayowa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [50] Transarterial chemoembolization in children to treat unresectable hepatocellular carcinoma
    Weiss, Krista E.
    Sze, Daniel Y.
    Rangaswami, Arun A.
    Esquivel, Carlos O.
    Concepcion, Waldo
    Lebowitz, Edward A.
    Kothary, Nishita
    Lungren, Matthew P.
    PEDIATRIC TRANSPLANTATION, 2018, 22 (04)